Release Date: 23/11/15 11:35 Summary: Pre-NR Request Notice - CVE Price Sensitive: Yes Download Document 7.86KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%